Surface Plasmon Resonance Market, by Product Type & Application (Drug Discovery (Drug Formulation, Controlled Drug Release, Drug-cell Interactions, (Material Science, Biosensors, & by Region - Size, Share, Outlook, & Opportunity Analysis, 2023-2030

Surface Plasmon Resonance (SPR) is an optical technique used for real time, label free detection of molecular interactions between mobile molecules with molecule immobilized on a thin metal film. Surface plasmon systems are used in pharmaceutical industry for drug discovery, and quality control. The identification of the molecule is based upon the interaction specificity of the molecule attached on the surface. Surface plasmon resonance helps in determining the specificity, affinity, and kinetic properties of the molecule. This generates electron charge density waves called plasmons, reducing the intensity of reflected light at a specific angle known as the resonance angle, in proportion to the mass on a sensor surface. Biacore Surface Plasmon Resonance (SPR) systems are used primarily in pharmaceutical development, quality control, and basic life science research. Based on the physical mechanism and the peculiar properties of Surface Plasmon Resonance (SPR), emonstrate the major applications of SPPs, such as waveguides, sources, near-field optics, surface-enhanced Raman spectroscopy, data storage, solar cells, chemical sensors and biosensors.

Surface plasmon resonance technology is useful to monitor biomolecular binding interactions in real-time. It has several advantages over other techniques such as real-time monitoring, label-free detection, small sample size requirement, reusable sensor chips, use of complex samples, and shorter experimental runs. SPR enables the highly sensitive and label-free assessment of affinity, kinetics and thermodynamics for ligand target interactions. In the drug discovery process, appropriate use of biophysical instrumentation can help advance hits earlier and more efficiently.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as increasing product launch of surface plasmon resonance in the field of drug discovery by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in Biosensing Instrument Inc. is a life science company that designs award winning label-free molecular interaction instruments using the SPR technology has introduced the Surface plasmon resonance Microscopy system, which is available commercially for interactions research. This move has redefined the use of surface plasmon resonance technology nad provides kinetic studies with single instrument.

Key features of the study:

• his report provides in-depth analysis of the Surface Plasmon Resonance Market and provides market size (US$ 921.3 million) and compound annual growth rate (CAGR 6.5%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global Surface Plasmon Resonance market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Bio-Rad Laboratories, Inc., Carterra Inc., General Electric Co., AMETEK, Inc., Bristol Myers Squibb, Horiba, Ltd., Bruker, and Biosensing Instrument Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Surface Plasmon Resonance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Surface Plasmon Resonance market

Detailed Segmentation:

• Global Surface Plasmon Resonance Market, By Product Type:
  • Imaging System
  • Sensor System
  • Reagents
• Global Surface Plasmon Resonance Market, By Application:
  • Drug Discovery
    • Drug Formulation
    • Controlled Drug Release
    • Drug-cell Interactions
  • Material Science
    • New Material and Coatings
    • Process Optimization
  • Biosensors
    • Food Safety
    • Environmental Safety
    • Cancer
    • DNA
    • Nanosafety
• Global Surface Plasmon Resonance Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Bio-Rad Laboratories, Inc. *
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Carterra Inc.
  • AMETEK, Inc.
  • Bristol Myers Squibb
  • Horiba, Ltd.
  • Bruker
  • Biosensing Instrument Inc.

"*" marked represents similar segmentation in other categories in the respective section.